Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search

1 results
12:00 AM, Oct 02, 2014  |  BC Innovations | Strategy

A conversation with Jeffrey Settleman

inhibitors approved in U.S. by year. Counts for 2014 exclude Chugai Pharmaceutical Co. Ltd. 's Alecensa
alectinib, a small molecule anaplastic lymphoma kinase ( ALK ) inhibitor marketed in Japan to treat …